1. Home
  2. YOUL vs GANX Comparison

YOUL vs GANX Comparison

Compare YOUL & GANX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

YOUL

Youlife Group Inc. American Depositary Shares

HOLD

Current Price

$0.45

Market Cap

73.0M

Sector

Real Estate

ML Signal

HOLD

Logo Gain Therapeutics Inc.

GANX

Gain Therapeutics Inc.

HOLD

Current Price

$1.88

Market Cap

76.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
YOUL
GANX
Founded
2020
2017
Country
China
United States
Employees
424
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
73.0M
76.4M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
YOUL
GANX
Price
$0.45
$1.88
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$7.50
AVG Volume (30 Days)
1.8M
654.5K
Earning Date
04-28-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
31.46
EPS
N/A
N/A
Revenue
N/A
$55,180.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.29
$1.41
52 Week High
$4.40
$4.34

Technical Indicators

Market Signals
Indicator
YOUL
GANX
Relative Strength Index (RSI) 43.75 55.83
Support Level $0.38 $1.73
Resistance Level $1.06 $2.12
Average True Range (ATR) 0.18 0.11
MACD -0.00 0.01
Stochastic Oscillator 16.91 68.09

Price Performance

Historical Comparison
YOUL
GANX

About YOUL Youlife Group Inc. American Depositary Shares

Youlife Group Inc is a blue-collar lifetime service platform in China, dedicated to serving the needs throughout the entire life cycle of the blue-collar talent. It provides blue-collar lifetime services to students, blue-collar talent, and corporate customers. Its segments are the vocational education segment, which engages in the provision of vocational education entrusted management services, self-operated vocational school services, and Others; the HR recruitment segment engages in the provision of HR recruitment services regarding blue-collar talent to customers; the employee management segment engages in the provision of labor outsourcing services, labor dispatch services and others; and the market service segment engages in the provision of value-added services.

About GANX Gain Therapeutics Inc.

Gain Therapeutics Inc is a clinical-stage biotechnology company developing novel small-molecule therapeutics to treat diseases across several therapeutic areas, including central nervous system (CNS) disorders, lysosomal storage disorders (LSDs), metabolic disorders, and other diseases that can be targeted through protein degradation, such as oncology. The Company's clinical stage product candidate, GT-02287, is being developed for the treatment of Parkinson's disease with and without GBA1 mutations. The Company generated an extensive preclinical data package providing evidence of the mechanism of action.

Share on Social Networks: